Quarterly Financial Data (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 7,560	$ 5,888	$ 5,867	$ 3,172	$ 5,276	$ 4,118	$ 4,489	$ 4,056	$ 22,487,566	$ 17,938,790	$ 14,668,455
Operating Costs and Expenses	67,269	16,271	31,536	21,260	20,830	20,376	16,919	17,555
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(33,228)	(11,393)	(17,158)	(19,231)	(11,691)	(17,177)	(12,769)	(13,830)
Net Income (Loss) Attributable to Parent	$ (33,197)	$ (11,376)	$ (17,126)	$ (19,187)	$ (11,612)	$ (16,974)	$ (12,605)	$ (13,682)
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders	$ (0.59)	$ (0.21)	$ (0.38)	$ (0.51)	$ (0.32)	$ (0.48)	$ (0.40)	$ (0.49)	$ (1.67)	$ (1.68)	$ (1.90)